Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln (updated)
11/02/2025 06:48
(Adds detail and quotes from statement in paragraphs 2-4)
COPENHAGEN, Feb 11 (Reuters) - Novonesis NSISb.CO said
on Tuesday that it had agreed to buy the stake of its partner,
Swiss-Dutch chemical manufacturer DSM-Firmenich, in their joint
enzymes venture for 1.5 billion euros ($1.55 billion).
The Danish company, created from the
merger
of food ingredients and enzymes makers Novozymes and Chr.
Hansen, said the so-called Feed Enzyme Alliance would be
dissolved and Novonesis would take over its sales and
distribution activities.
"Growing global protein demand, coupled with increasing
land and water scarcity, requires innovative solutions,"
Novonesis CEO Ester Baiget said in a statement.
"Now with an expanded presence across the animal
biosolutions value chain, we are better positioned to create
more value for customers with sustainable value adding
biosolutions".
(Reporting by Stine Jacobsen, editing by Terje Solsvik)
((stine.jacobsen@thomsonreuters.com; +45 2156 90 10;))